foscarnet has been researched along with B Virus Infection in 54 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Excerpt | Relevance | Reference |
---|---|---|
"Persons with AIDS who have CD4+ counts < or = 100 and transplant patients, especially bone marrow allograft recipients, may experience clinically significant infections with acyclovir-resistant herpes simplex virus (HSV) or varicella-zoster virus (VZV)." | 8.79 | Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. ( Balfour, HH; Benson, C; Braun, J; Cassens, B; Erice, A; Friedman-Kien, A; Klein, T; Polsky, B; Safrin, S, 1994) |
" Combination therapy with Interferon-α and ribavirin remains the backbone treatment for chronic hepatitis C; the addition of serine protease inhibitors improves the treatment outcome of patients infected with hepatitis C virus genotype 1." | 4.87 | Antiviral drugs for viruses other than human immunodeficiency virus. ( Razonable, RR, 2011) |
"Persons with AIDS who have CD4+ counts < or = 100 and transplant patients, especially bone marrow allograft recipients, may experience clinically significant infections with acyclovir-resistant herpes simplex virus (HSV) or varicella-zoster virus (VZV)." | 4.79 | Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. ( Balfour, HH; Benson, C; Braun, J; Cassens, B; Erice, A; Friedman-Kien, A; Klein, T; Polsky, B; Safrin, S, 1994) |
" Herpes virus type 1 and rarely type 2 may lead to painful and resistant oral ulcers, and systemic treatment with acyclovir, valaciclovir or famciclovir is indicated." | 4.79 | Viral lesions of the mouth in HIV-infected patients. ( Itin, PH; Lautenschlager, S, 1997) |
" These questions concern appropriate routes of administration for antiviral compounds, optimal dosage regimens, risks of long-term prophylaxis, and the emergence of resistant organisms." | 2.66 | Antiviral chemotherapy and chemoprophylaxis. ( Dolin, R, 1985) |
"Foscarnet has also been shown to be effective as preemptive therapy for CMV in allogenic stem cell transplant patients and as therapy for aciclovir-resistant HSV infections." | 2.41 | Prophylaxis against herpesvirus infections in transplant recipients. ( Ljungman, P, 2001) |
" In patients with renal insufficiency, careful dosage adjustment is mandatory to optimize drug exposure and reduce the risk for adverse events." | 2.41 | Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD). ( Deray, G; Issad, B; Izzedine, H; Launay-Vacher, V, 2002) |
"Foscarnet treatment has been used with some clinical benefit in patients with acyclovir-resistant HSV or VZV, or ganciclovir-resistant CMV." | 2.39 | Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. ( Reusser, P, 1996) |
" Current work includes the development of increased bioavailability prodrugs (BW 256, famciclovir), which are converted to active drug once absorbed, enabling rapid high serum levels, and hence may turn out to have increased efficacy in HSV- and VZV-induced diseases, for which oral acyclovir currently is the treatment of choice." | 2.38 | Systemic antivirals in herpesvirus infections. ( Sacks, SL; Sasadeusz, JJ, 1993) |
"A treatment with foscarnet was administered and clinical improvement was observed as early as the fourth day, with complete reepithelialization 50 days later." | 1.29 | [Chronic herpes resistant to acyclovir in a patient with AIDS]. ( About, I; Bernard, P; Capdeville, J; Massip, P, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (7.41) | 18.7374 |
1990's | 34 (62.96) | 18.2507 |
2000's | 11 (20.37) | 29.6817 |
2010's | 4 (7.41) | 24.3611 |
2020's | 1 (1.85) | 2.80 |
Authors | Studies |
---|---|
Prichard, MN | 1 |
Quenelle, DC | 1 |
Hartline, CB | 1 |
Harden, EA | 1 |
Jefferson, G | 1 |
Frederick, SL | 1 |
Daily, SL | 1 |
Whitley, RJ | 1 |
Tiwari, KN | 1 |
Maddry, JA | 1 |
Secrist, JA | 1 |
Kern, ER | 1 |
Kotton, BD | 1 |
Kotton, CN | 1 |
Piret, J | 1 |
Boivin, G | 1 |
Baldwin, K | 1 |
Capobianchi, A | 1 |
Iori, AP | 1 |
Mauro, FR | 1 |
Torelli, GF | 1 |
Micozzi, A | 1 |
Girmenia, C | 1 |
Foà, R | 1 |
Gentile, G | 1 |
Razonable, RR | 1 |
Shiraki, K | 1 |
Nash, PJ | 1 |
Avery, RK | 1 |
Tang, WH | 1 |
Starling, RC | 1 |
Taege, AJ | 1 |
Yamani, MH | 1 |
Tan, HH | 1 |
Goh, CL | 1 |
Oberg, B | 1 |
Oxford, JS | 1 |
Vindevogel, H | 1 |
Pastoret, PP | 1 |
Aguilar-Setien, A | 1 |
About, I | 1 |
Capdeville, J | 1 |
Bernard, P | 1 |
Massip, P | 1 |
Lusso, P | 1 |
Gallo, RC | 2 |
Smee, DF | 1 |
Barnett, BB | 1 |
Sidwell, RW | 1 |
Reist, EJ | 1 |
Holy, A | 1 |
Jones, JL | 1 |
Hanson, DL | 1 |
Chu, SY | 1 |
Ward, JW | 1 |
Jaffe, HW | 1 |
Albrecht, H | 1 |
Stellbrink, HJ | 1 |
Brewster, D | 1 |
Greten, H | 1 |
Stamminger, T | 1 |
Fleckenstein, B | 1 |
Balfour, HH | 1 |
Benson, C | 1 |
Braun, J | 1 |
Cassens, B | 1 |
Erice, A | 1 |
Friedman-Kien, A | 1 |
Klein, T | 1 |
Polsky, B | 1 |
Safrin, S | 1 |
Collins, P | 1 |
Sasadeusz, JJ | 1 |
Sacks, SL | 1 |
Drobyski, WR | 1 |
Dunne, WM | 1 |
Burd, EM | 1 |
Knox, KK | 1 |
Ash, RC | 1 |
Horowitz, MM | 1 |
Flomenberg, N | 1 |
Carrigan, DR | 1 |
Glesby, MJ | 1 |
Hoover, DR | 1 |
Weng, S | 1 |
Graham, NM | 1 |
Phair, JP | 1 |
Detels, R | 1 |
Ho, M | 1 |
Saah, AJ | 1 |
Humphrey, RW | 1 |
O'Brien, TR | 1 |
Newcomb, FM | 1 |
Nishihara, H | 1 |
Wyvill, KM | 1 |
Ramos, GA | 1 |
Saville, MW | 1 |
Goedert, JJ | 1 |
Straus, SE | 1 |
Yarchoan, R | 1 |
Reusser, P | 2 |
Cordonnier, C | 1 |
Einsele, H | 2 |
Engelhard, D | 1 |
Link, D | 1 |
Locasciulli, A | 1 |
Ljungman, P | 2 |
Itin, PH | 1 |
Lautenschlager, S | 1 |
Grose, C | 1 |
Secchiero, P | 1 |
Gibellini, D | 1 |
Flamand, L | 1 |
Robuffo, I | 1 |
Marchisio, M | 1 |
Capitani, S | 1 |
Zauli, G | 1 |
Takahashi, K | 1 |
Tanaka-Taya, K | 1 |
Okada, S | 1 |
Rieux, C | 1 |
Gautheret-Dejean, A | 2 |
Challine-Lehmann, D | 1 |
Kirch, C | 1 |
Agut, H | 2 |
Vernant, JP | 1 |
Chatelain, E | 1 |
Deminière, C | 1 |
Lacut, JY | 1 |
Potaux, L | 1 |
Cole, PD | 1 |
Stiles, J | 1 |
Boulad, F | 1 |
Small, TN | 1 |
O'Reilly, RJ | 1 |
George, D | 1 |
Szabolcs, P | 1 |
Kiehn, TE | 1 |
Kernan, NA | 1 |
Zeichner, SL | 1 |
Johnston, RE | 1 |
Geretti, AM | 1 |
Prentice, HG | 1 |
Clark, AD | 1 |
Wheeler, AC | 1 |
Potter, M | 1 |
Griffiths, PD | 1 |
Tiacci, E | 1 |
Luppi, M | 1 |
Barozzi, P | 1 |
Gurdo, G | 1 |
Tabilio, A | 1 |
Ballanti, S | 1 |
Torelli, G | 1 |
Aversa, F | 1 |
Bethge, W | 1 |
Beck, R | 1 |
Jahn, G | 1 |
Mundinger, P | 1 |
Kanz, L | 1 |
Manichanh, C | 1 |
Grenot, P | 1 |
Debré, P | 1 |
Huraux, JM | 1 |
Drew, WL | 1 |
Bowers, M | 1 |
Naesens, L | 1 |
De Clercq, E | 1 |
Izzedine, H | 1 |
Launay-Vacher, V | 1 |
Issad, B | 1 |
Deray, G | 1 |
Masur, H | 1 |
Smejkal, F | 1 |
Otová, B | 1 |
Zikán, V | 1 |
Roubínek, F | 1 |
Jacobson, MA | 1 |
Degré, M | 1 |
Moeland, A | 1 |
Bruun, JN | 1 |
Epstein, JB | 1 |
Dolin, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies[NCT00002272] | 0 participants | Interventional | Completed | ||||
An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies[NCT00002021] | 0 participants | Interventional | Completed | ||||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
22 reviews available for foscarnet and B Virus Infection
Article | Year |
---|---|
Resistant herpes simplex virus infections - who, when, and what's new?
Topics: Acyclovir; Antiviral Agents; Cytosine; Foscarnet; Herpes Simplex; Herpesviridae Infections; Humans; | 2022 |
Antiviral drug resistance in herpesviruses other than cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Foscarnet | 2014 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; | 2011 |
[Anti-herpetic chemotherapeutic drugs].
Topics: Acyclovir; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpesviridae; Herpesvir | 2003 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Ad | 2006 |
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).
Topics: Animals; Antiviral Agents; Cell-Free System; Cells, Cultured; Chemical Phenomena; Chemistry; DNA-Dir | 1982 |
Human herpesvirus 6.
Topics: Acquired Immunodeficiency Syndrome; Adult; Animals; Antibodies, Viral; Base Sequence; Child; Child, | 1995 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Mechanisms of herpes virus resistance.
Topics: Acyclovir; Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviri | 1993 |
Systemic antivirals in herpesvirus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Animals; Antiviral Agents; Clinical Trials as Topic; | 1993 |
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famcicl | 1996 |
Viral lesions of the mouth in HIV-infected patients.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus In | 1997 |
Childhood infections with human herpesviruses types 6, 7, and 8.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Antiviral Agents; Burkitt Lymphoma; Central Nervous | 1996 |
[Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Topics: Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, | 1998 |
[Human herpesvirus-6 and -7 infection and bone marrow transplantation (BMT)].
Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Bone Marrow Transplantation; Foscarnet; gamma-Globul | 1998 |
Prophylaxis against herpesvirus infections in transplant recipients.
Topics: Antibiotic Prophylaxis; Antiviral Agents; Cidofovir; Cytosine; Foscarnet; Hematopoietic Stem Cell Tr | 2001 |
Recent developments in herpesvirus therapy.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Cl | 2001 |
Anti-viral drugs in continuous ambulatory peritoneal dialysis (CAPD).
Topics: Adamantane; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Dideoxynucleosides; Foscarnet; Hepat | 2002 |
Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Comb | 1992 |
[Antiviral agents for the systemic treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Phosphonoacet | 1991 |
[Treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganc | 1991 |
Antiviral therapeutics in dentistry.
Topics: Acyclovir; Antiviral Agents; Dental Care; Drug Combinations; Drug Resistance, Microbial; Foscarnet; | 1991 |
2 trials available for foscarnet and B Virus Infection
Article | Year |
---|---|
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bisexuality; Case-Control Studie | 1996 |
Antiviral chemotherapy and chemoprophylaxis.
Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomega | 1985 |
30 other studies available for foscarnet and B Virus Infection
Article | Year |
---|---|
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Topics: Animals; Antiviral Agents; Cell Line; Cell Proliferation; Cells, Cultured; DNA-Directed DNA Polymera | 2009 |
Ganciclovir-resistant human herpesvirus-6 encephalitis in a liver transplant patient: a case report.
Topics: Aged; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Encephalitis, Viral; Foscarnet; Ganciclo | 2011 |
Longitudinal analysis of human herpesvirus-8 DNA and antibodies in an Italian allogeneic stem cell transplant recipient.
Topics: Antibodies, Viral; Cidofovir; Cytosine; DNA, Viral; Encephalitis; Fatal Outcome; Foscarnet; Ganciclo | 2011 |
Encephalitis owing to human herpesvirus-6 after cardiac transplant.
Topics: Adult; Antiviral Agents; Cytomegalovirus; DNA, Viral; Encephalitis; Foscarnet; Heart Transplantation | 2004 |
Chemotherapy of influenza and herpes virus infections.
Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Foscarnet; Guanine; Herpesviridae Infect | 1981 |
Assessment of phosphonoformate-treatment of pigeon herpesvirus infection in pigeons and budgerigars and Aujeszky's disease in rabbits.
Topics: Animals; Antiviral Agents; Bird Diseases; Birds; Columbidae; Foscarnet; Herpesviridae Infections; Or | 1982 |
[Chronic herpes resistant to acyclovir in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Buttocks; Chronic Disease; Drug Resistance; Fo | 1994 |
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Foscarnet; Ga | 1995 |
AIDS-associated Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Opportunistic Infections; Female; Foscar | 1995 |
Resolution of oral hairy leukoplakia during treatment with foscarnet.
Topics: Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Foscarnet; Herpesviridae In | 1994 |
[Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].
Topics: AIDS-Related Opportunistic Infections; Didanosine; Dose-Response Relationship, Drug; Drug Administra | 1994 |
Human herpesvirus-6 (HHV-6) infection in allogeneic bone marrow transplant recipients: evidence of a marrow-suppressive role for HHV-6 in vivo.
Topics: Adult; Base Sequence; Bone Marrow; Bone Marrow Transplantation; Cohort Studies; Colony-Forming Units | 1993 |
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Base Sequence; Blood Coagulation Disord | 1996 |
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Data Collection; Drug Res | 1996 |
Isolation of new transmissible herpesvirus suggests additional therapeutic approaches for KS.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; DNA, Viral; Foscarnet; Herpesviridae; Herpesvi | 1996 |
Human herpesvirus 7 induces the down-regulation of CD4 antigen in lymphoid T cells without affecting p56lck levels.
Topics: Antigens, Viral; CD4 Antigens; CD4-Positive T-Lymphocytes; Cell Line, Transformed; Down-Regulation; | 1997 |
Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation.
Topics: Acute Disease; Adult; Antiviral Agents; Bone Marrow Transplantation; Female; Foscarnet; Ganciclovir; | 1998 |
Severe renal failure and polyneuritis induced by foscarnet.
Topics: Acute Kidney Injury; Adult; Antiviral Agents; Female; Foscarnet; Herpesviridae Infections; Humans; I | 1998 |
Successful treatment of human herpesvirus 6 encephalitis in a bone marrow transplant recipient.
Topics: Adolescent; Antiviral Agents; Bone Marrow Transplantation; Encephalitis, Viral; Female; Foscarnet; H | 1998 |
Foscarnet.
Topics: Antiviral Agents; Cytomegalovirus Retinitis; Foscarnet; Herpesviridae Infections; Humans | 1998 |
HHV-6-related secondary graft failure following allogeneic bone marrow transplantation.
Topics: Antiviral Agents; Bone Marrow Diseases; Bone Marrow Transplantation; Child; Diagnosis, Differential; | 1999 |
Fatal herpesvirus-6 encephalitis in a recipient of a T-cell-depleted peripheral blood stem cell transplant from a 3-loci mismatched related donor.
Topics: Cytomegalovirus Infections; DNA, Viral; Encephalitis, Viral; Fatal Outcome; Foscarnet; Ganciclovir; | 2000 |
Successful treatment of human herpesvirus-6 encephalitis after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Combined Modality Therapy; DNA, Viral; Encephalitis, Viral; Fema | 1999 |
Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Topics: Antibodies, Monoclonal; Antigens, Surface; Antigens, Viral; Antiviral Agents; Cidofovir; Cytosine; D | 2000 |
Ganciclovir resistance: a matter of time and titre.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; C | 2000 |
Herpesviruses.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Cidofovir; Complementary Therapi | 1995 |
Herpesvirus treatment for KS.
Topics: Antiviral Agents; Eligibility Determination; Foscarnet; Herpesviridae Infections; Humans; Sarcoma, K | 1995 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antivi | 2002 |
Clinical implications of herpesvirus infections in patients with AIDS. Introduction.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1992 |
[Effectiveness of phosphonoformic acid in herpes infections].
Topics: Animals; Antiviral Agents; Foscarnet; Guinea Pigs; Herpesviridae; Herpesviridae Infections; Phosphon | 1992 |